Retatrutide vs Tirzepatide: The Next-Gen GLP-1 Showdown

Tirzepatide is the current heavyweight champ of weight loss. Retatrutide is the challenger everyone is watching - newer, possibly stronger, but not on the shelf yet. Here is how they actually compare, and which one makes sense depending on where you are.

The quick answer

In the trial data, retatrutide has posted bigger weight-loss numbers than tirzepatide - but it is not approved or available the way tirzepatide is. So it comes down to this: tirzepatide is the proven, accessible option; retatrutide is the cutting-edge one you cannot legally get through a pharmacy yet.

How they work (the real difference)

This is the headline difference:

Tirzepatide is a dual agonist - it hits two hormone targets, GLP-1 and GIP.

Retatrutide is a triple agonist - it hits three: GLP-1, GIP, and glucagon. That third target (glucagon) is the leading reason researchers think it may drive even more fat loss. More levers, potentially more effect.

If you want each mechanism on its own, see How Tirzepatide Works and How Retatrutide Works.

Weight loss results compared

Both are in a different league from older drugs, but retatrutide's trial numbers have been the highest recorded in the class. Late-stage retatrutide trials have reported average weight loss in the high-20s percent of body weight, while tirzepatide's top results land around the low-20s.

Big caveat: those retatrutide numbers come from clinical trials, not real-world use, because it is still in testing. Impressive on paper - but paper is not the pharmacy yet.

Availability (the dealbreaker)

This is where they really part ways:

Tirzepatide is approved and available by prescription (as Mounjaro and Zepbound).

Retatrutide is investigational. As of now it is still in Phase 3 trials, not FDA approved, and cannot be legally prescribed or compounded - the only legitimate access is a clinical trial. Anything else is grey-market. We keep the current status updated in Is Retatrutide Available Yet?.

Side effects

Broadly similar - both are GLP-1-based, so expect the same family of gut side effects (nausea, GI upset), especially while titrating. Retatrutide's added glucagon activity is still being studied, which is part of why the ongoing trials matter.

Can you take both together?

People ask this, so: there is no good data on stacking two GLP-1 agonists, and doubling up on the same class is not a recognized protocol. This is not a "stack them for double results" situation. If you are thinking about how GLP-1s fit alongside other peptides, the useful direction is muscle preservation, not running two GLP-1s at once - see What to Stack With Tirzepatide.

Which should you choose?

• Want something proven and actually obtainable? Tirzepatide. It works and you can get it legally.
• Chasing the absolute frontier and following the trials? Retatrutide is the one to watch - but understand it is not legitimately available yet.

For most people making a decision today, tirzepatide is the practical answer. Retatrutide is the one to keep an eye on.

Quick FAQ

Is retatrutide better than tirzepatide? On trial weight-loss numbers, retatrutide has come out higher. But it is not approved or available like tirzepatide, so "better" depends on whether you can actually get it.

Are retatrutide and tirzepatide the same? No. Tirzepatide is a dual agonist (GLP-1, GIP); retatrutide is a triple agonist (GLP-1, GIP, glucagon).

Can I take tirzepatide and retatrutide together? There is no solid data supporting running two GLP-1 agonists at once. It is not an established protocol.

Is retatrutide available yet? Not as an approved medication - it remains in trials. Check our availability guide for the current status.

---

This is educational info for research purposes, not medical advice. Retatrutide is investigational and not approved; tirzepatide is a prescription medication. Consult a healthcare professional.